Most Cited
| Year | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| No. of Published Articles | 240 | 480 | 760 | 633 | 702 | 655 | 622 | 661 | 702 | 5455 |
| Citations | 2027 | 3470 | 4084 | 2232 | 1602 | 1043 | 678 | 392 | 51 | 15579 |
| Article published in 2010 and 2011: 720, Citation in 2012 to articles Published in 2010 and 2011- 5497 Impact Factor (2012): 5497/720 = 7.63 (On the basis of citations) Article published in 2011 and 2012: 1240, Citation in 2013 to articles Published in 2011 and 2012- 7554 Impact Factor (2013): 7554/1240 = 6.09 (On the basis of citations) Article published in 2012 and 2013: 1393, Citation in 2014 to articles Published in 2012 and 2013- 6316 Impact Factor (2014): 6316/1393 = 4.53 (On the basis of citations) Article published in 2013 and 2014: 1335, Citation in 2015 to articles Published in 2013 and 2014- 3834 Impact Factor (2015): 3834/1335 = 2.87 (On the basis of citations) Article published in 2014 and 2015: 1357, Citation in 2016 to articles Published in 2014 and 2015- 2645 Impact Factor (2016): 2645/1357 = 1.94 (On the basis of citations) Article published in 2015 and 2016: 1277, Citation in 2017 to articles Published in 2015 and 2016- 1721 Impact Factor (2017): 1721/1277 = 1.34 (On the basis of citations) Article published in 2016 and 2017: 1283, Citation in 2018 to articles Published in 2016 and 2017- 1070 Impact Factor (2018): 1070/1283 = 0.83 (On the basis of citations) Five Year Projected Impact Factor: 5947/3273 = 1.81 |
||||||||||
KAWASAKI SYNDROME- A REVIEW
Aim: The aim of this review is to provide a detailed documentation and main features such as prevalance, manifestations and management regarding Kawasaki syndrome. Background: Kawasaki Syndrome was first described by Dr Tomisaku Kawasaki in Japan in 1967, since then prevalence of Kawasaki syndrome is increasing in all countries as per the reports in journals. This is more prevalent in Asian pacifi...
3155
953
SYNTHESIS AND CHARACTERIZATION OF SITE SPECIFIC SUPERPOROUS HYDROGEL HYBRIDS OF LORATADINE
The aim of present study is to formulate and optimize the site specific controlled release formulation for release of loratadine in upper gastrointestinal tract. Superposrous hydrogel hybrids (SPHH) were prepared by using ferric chloride as crosslinking agent and sodium carboxymethyl cellulose as composite agent. The Superporous Hydrogels were evaluated for swelling ratio, mechanical strength, den...
2140
580
SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL STUDIES OF 3-SUBSTITUTED SCHIFF BASES OF QUINAZOLINE2,4-DIONES
Objective: 3-Substituted Schiff bases of Quinazolne-2,4-diones belongs to the N-containing heterocyclic compounds. The aim of the present study is to synthesis and characterization of ten novel derivatives of 3-Substituted Schiff bases of Quinazoline2,4-diones and their pharmacological study. In the current course of work the novel Schiff bases of Quinazolne-2,4-diones which are synthesized ar...
1932
797
FUNCTIONALIZATION OF THE SELECTED REGENERATED CELLULOSIC FABRICS WITH HERBAL OIL AND EVALUATE THE FUNCTIONAL PROPERTIES
In this study, an attempt has been made to approach of developing antibacterial finish using aromatic herbal oils. The five different herbal oils like Palmarosa, Petitgrain, Tea tree, Thyme, Lavender oil were screened with disc diffusion method against bacteria that normally exist like Staphylococcus aureus, Escherichia coli. The result showed good efficiency in Thyme oil when compared to other oi...
1756
866
ANXIOLYTIC AND MOTOR COORDINATION ACTIVITY OF HUPERZINE-A IN RATS
The aim of the present study was to evaluate the anxiolytic effects and motor coordination activity of Huperzine-A in rats. Wistar rats were treated orally with Huperzine-A (0.5, 1, 2 & 4 mg/kg) and diazepam (2 mg/kg p.o) as a standard anxiolytic drug then exposed to Elevated plus Maze (EPM) and Light Dark Box (LDB). The effects of the Huperzine-A on motor coordination were evaluated by actoph...
2464
555
BIOMARKERS – ITS ROLE IN MEDICINE
Biomarker is a measurable indicator of the severity or presence of some disease state. It is introduced into an organism as a means to examine organ function or other aspects of health. Biomarkers play a major role in medicinal biology. They help in early diagnosis, disease prevention, drug target identification, drug response etc. Several biomarkers have been identified for many diseases such as ...
2991
877
APOPTOSIS SIGNALING; A DRUG DESIGN IN CANCER THERAPY: A REVIEW
Apoptosis plays an important role in development, growth, differentiation, altered gravity conditions, tissue homeostasis, immune defense, and cancer to control cell number in tissues and to eliminate individual cells that threaten the animal’s survival. The purposes of this review are to describe the signaling pathways and the cellular changes that occur with apoptosis. Currently, two pathways ...
1433
551
A COMPARATIVE STUDY OF DOT AND SAT IN RURAL TERTIARY CARE HOSPITAL: A TWO YEARS RETROSPECTIVE STUDY
Directly observed therapy (DOT) of tuberculosis patients talking their drugs is supposed to improve treatment completion and outcome .we compared DOT and Self Administered therapy (SAT), in which patients on the same drug regimen are not, observed taking their pills, to assess the effect of each on the success of tuberculosis treatment. This was the two year (2010 and 2011) retrospective study of ...
1458
646
EVALUATION OF ANTIOXIDANT AND ANTIMICROBIAL ACTIVITY OF A MEDICINAL PLANT HYDROCOTYLE SIBTHORPIODES LAM., GROWN IN NE INDIA
The present study was conducted to evaluate the antioxidant and antibacterial activities of methanol and aqueous extracts of whole plant of Hydrocotyle sibthorpiodes Lam. Antioxidant activity was measured using reducing power, hydrogen peroxide and 2, 2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assays. The antioxidant activity was expressed as percentage (%) of DPPH and H2O2 radical...
1818
505
A PRELIMINARY INVESTIGATION OF TUMOR TAKE INHIBITORY ACTIVITY OF ETHANOLIC LEAF EXTRACT OF MURRAYA KOENIGII LINN. IN MICE
The present study was undertaken to explore the tumor take inhibitory effects of ethanolic extract of Murraya koenigii in rodents. Tumor take inhibitory activity was investigated in hybrid mice (of C57BL strain + Swiss albino strain). Preventive group animals were injected daily with the extract at dose of 50mg/kg body weight i.p. for 10 consecutive days. The animals were observed for the growth o...
894
290